Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.
Related posts
-
What to do in Chicago: Groundhog Days in Woodstock, comedian Jimmy O. Yang and an early start on Lunar New Year
Also around the area this weekend, the Chicago Travel and Adventure Show lands in Rosemont and... -
Suburban skaters mourn D.C. plane crash victims they’d just seen at Kansas competition
Some of the victims on the American Eagle flight that crashed into the Potomac River after... -
Suburban skaters mourn D.C. plane crash victims they’d just seen at Kansas competition
Some of the victims on the American Eagle flight that crashed into the Potomac River after...